Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | LINCOLN Lincoln Pharmaceuticals Limited Pharma · Small | SURAKSHA Suraksha Diagnostic Limited Pharma · Small | SYNCOMF Syncom Formulations (India) Limited Pharma · Small | KRSNAA Krsnaa Diagnostics Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 45 | 51 | 65 | 47 |
| Verdict | WATCHLIST | FAIR VALUE | UNDERVALUED | FAIR VALUE |
| Style | Financial Turnaround | Financial Turnaround | Financial Turnaround | Financial Turnaround |
| Piotroski | 8/9 | 8/9 | 8/9 | 8/9 |
| Valuation | 15/30 | 2/30 | 14/30 | 19/30 |
| Growth | 7/25 | 21/25 | 13/25 | 13/25 |
| Quality | 2/20 | 8/20 | 16/20 | 1/20 |
| Balance Sheet | 12/15 | 7/15 | 11/15 | 7/15 |
| Cash Flow | 4/10 | 8/10 | 6/10 | 1/10 |
| Price | ₹637.8 | ₹269.65 | ₹14.55 | ₹544.35 |
| P/E | 14.50 | 43.70 | 17.90 | 17.40 |
| P/B | 1.69 | 5.74 | 3.31 | 1.80 |
| ROE | 12.30% | 14.10% | 20.20% | 10.90% |
| ROCE | 16.30% | 17.00% | 26.80% | 12.70% |
| Debt / Equity | 0.01 | 0.53 | 0.00 | 0.54 |
| FCF Yield | 0.63% | 2.13% | 0.51% | — |
| Dividend Y | 0.28% | — | — | 0.51% |
| Altman Z | 8.39 | 6.45 | 8.51 | 3.00 |
| Promoter % | 49.78% | 49.10% | 50.57% | 27.11% |
| Mkt Cap (₹Cr) | 1277.00 | 1406.00 | 1368.00 | 1766.00 |
| Graham # | ₹610.9 | ₹80.84 | ₹8.97 | ₹460.96 |
| Fair PE | 19.1 | 42.0 | 42.3 | 30.3 |
| MoS % | +23.9% | -3.9% | +57.5% | +42.5% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startLINCOLN96
SURAKSHA65
SYNCOMF71
KRSNAA58